The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes

References

• Cheah PY. Recent advances in colorectal cancer genetics and diagnostics. Crit Rev Oncol/Hematol 2009; 69:45-55; PMID:18774731; https://doi.org/10.1016/j.critrevonc.2008.08.001
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA and Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009; 104:739-50; PMID:19240699; https://doi.org/10.1038/ajg.2009.104
   PubMed Web of Science ®Google Scholar
• Berg M, Søreide K. Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci 2011; 12:9426-39; PMID:22272141; https://doi.org/10.3390/ijms12129426
   PubMed Web of Science ®Google Scholar
• Stigliano V, Sanchez-Mete L, Martayan A, Anti M. Early-onset colorectal cancer: A sporadic or inherited disease? World J Gastroenterol: WJG 2014; 20:12420; PMID:25253942; https://doi.org/10.3748/wjg.v20.i35.12420
   PubMed Web of Science ®Google Scholar
• Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller R-U, Straka E, Su L, Burki EA. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non–small cell lung cancer risk. Cancer Res 2008; 68:8535-40; PMID:18922928; https://doi.org/10.1158/0008-5472.CAN-08-2129
   PubMed Web of Science ®Google Scholar
• Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009; 8:1067-74; PMID:19435867; https://doi.org/10.1158/1535-7163.MCT-08-0592
   PubMed Web of Science ®Google Scholar
• Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y. MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 2013; 12:30; PMID:23617834; https://doi.org/10.1186/1476-4598-12-30
   PubMed Web of Science ®Google Scholar
• Sætrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 2009; 69:7459-65; PMID:19738052; https://doi.org/10.1158/0008-5472.CAN-09-1201
   PubMed Web of Science ®Google Scholar
• Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, Fu X, Fan X, Wei Y, Yang L. NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PloS one 2011; 6:e21726; PMID:21738780; https://doi.org/10.1371/journal.pone.0021726
   PubMed Web of Science ®Google Scholar
• Chung H, Young DJ, Lopez CG, Le TA, Lee JK, Ream-Robinson D, Huang SC, Carethers JM. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair. PLoS One 2008; 3:21; PMID:18941508; https://doi.org/10.1371/annotation/2548989f-1f13-4ea5-8af8-62420b0a590e
   PubMed Web of Science ®Google Scholar
• Vilar E, Mukherjee B, Kuick R, Raskin L, Misek D E, Taylor J M, Giordano TJ, Hanash SM, Fearon ER, Rennert G, et al. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Clin Cancer Res 2009; 15:2829-39; PMID:19351759; https://doi.org/10.1158/1078-0432.CCR-08-2432
   PubMed Web of Science ®Google Scholar
• Li J, Liang H, Bai M, Ning T, Wang C, Fan Q, Wang Y, Fu Z, Wang N, Liu R. MiR-135b promotes cancer progression by targeting transforming growth factor beta receptor II (TGFBR2) in colorectal cancer. PloS one 2015; 10:e0130194; PMID:26061281; https://doi.org/10.1371/journal.pone.0130194
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; https://doi.org/10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S. MicroRNAs impair MET-mediated invasive growth. Cancer Res 2008; 68:10128-36; PMID:19074879; https://doi.org/10.1158/0008-5472.CAN-08-2148
   PubMed Web of Science ®Google Scholar
• Yue D, Liu H, Huang Y. Survey of computational algorithms for MicroRNA target prediction. Curr Genomics 2009; 10:478; PMID:20436875; https://doi.org/10.2174/138920209789208219
   PubMed Web of Science ®Google Scholar
• Koparde P, Singh S. Prediction of micro RNAs against H5N1 and H1N1 NS1 protein: a window to Sequence Specific Therapeutic Development. Journal of Data Mining in Genomics & Proteomics 2010; 1:2-8; https://doi.org/10.4172/2153-0602.1000104
   Google Scholar
• Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet 2001; 29:117-29; PMID:11586292; https://doi.org/10.1038/ng1001-117
   PubMed Web of Science ®Google Scholar
• Gryfe R, Bapat B, Gallinger S, Swallow C, Redston M, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997; 21:233-99; PMID:9438104; https://doi.org/10.1016/S0147-0272(97)80003-7
   PubMed Web of Science ®Google Scholar
• Biswas S, Trobridge P, Romero-Gallo J, Billheimer D, Myeroff LL, Willson JK, Markowitz SD, Grady WM. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer 2008; 47:95-106; PMID:17985359; https://doi.org/10.1002/gcc.20511
   PubMed Web of Science ®Google Scholar
• Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995; 55:5548-50; PMID:7585632
   PubMed Web of Science ®Google Scholar
• Lee J, Warnken U, Schnolzer M, Gebert J, Kopitz J. A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target. Protein Sci 2015; 24:1686-94; PMID:26177744; https://doi.org/10.1002/pro.2741
   PubMed Web of Science ®Google Scholar
• Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature 2003; 422:835-47; PMID:12695777; https://doi.org/10.1038/nature01626
   PubMed Web of Science ®Google Scholar
• Choudhury A, Hazelhurst S, Meintjes A, Achinike-Oduaran O, Aron S, Gamieldien J, Jalali Sefid Dashti M, Mulder N, Tiffin N, Ramsay M. Population-specific common SNPs reflect demographic histories and highlight regions of genomic plasticity with functional relevance. BMC Genomics 2014; 15:1471-2164; PMID:24906912; https://doi.org/10.1186/1471-2164-15-437
   PubMed Web of Science ®Google Scholar
• Bansal V, Libiger O, Torkamani A, Schork NJ. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010; 11:773-85; PMID:20940738; https://doi.org/10.1038/nrg2867
   PubMed Web of Science ®Google Scholar
• Li B, Leal SM. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008; 83:311-21; PMID:18691683; https://doi.org/10.1016/j.ajhg.2008.06.024
   PubMed Web of Science ®Google Scholar
• Mei Y, Yang JP, Qian CN. For robust big data analyses: a collection of 150 important pro-metastatic genes. Chin J Cancer 2017; 36:016-0178; PMID:28109319; https://doi.org/10.1186/s40880-016-0178-z
   PubMed Web of Science ®Google Scholar
• Ahluwalia JK, Hariharan M, Bargaje R, Pillai B, Brahmachari V. Incomplete penetrance and variable expressivity: is there a microRNA connection? Bioessays 2009; 31:981-92; PMID:19642110; https://doi.org/10.1002/bies.200900066
   PubMed Web of Science ®Google Scholar